Healthways (NAS: HWAY) filed its 10-K on Wednesday. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Healthways met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue dropped, and GAAP earnings per share shrank to a loss.
Margins dropped across the board.
Healthways reported revenue of $180 million. The nine analysts polled by S&P Capital IQ anticipated net sales of $181.5 million on the same basis. GAAP reported sales were 7.8% lower than the prior-year quarter's $195.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $0.27. The nine earnings estimates compiled by S&P Capital IQ forecast $0.33 per share on the same basis. GAAP EPS were -$5.32 for Q4 compared to $0.45 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 26%, 1,090 basis points worse than the prior-year quarter. Operating margin was 10.6%, 970 basis points worse than the prior-year quarter. Net margin was -98.4%, 10,640 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $155.9 million. On the bottom line, the average EPS estimate is $0.00.
Next year's average estimate for revenue is $674.4 million. The average EPS estimate is $0.46.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 394 members rating the stock outperform and 24 members rating it underperform. Among 152 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 145 give Healthways a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Healthways is hold, with an average price target of $8.50.
Over the decades, small-cap stocks, like Healthways have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
Add Healthways to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.